You’re gonna need a bigger moat

Your weekly update on top ETF trends
@BobPisani

KEY STORIES 

 
 
Biotech stocks are doing something that could result in a double-digit rally, trader says
The last five times the iShares' Biotechnology ETF (IBB) got this oversold, it subsequently rallied between 18% and 40%, says Miller Tabak's Matt Maley.
Historically volatile October could spark more inflows into ETFs, market analyst says
Volatility tends to drive investors toward exchange-traded funds, ETF Trends' Dave Nadig says.
Watch now: ETF Edge on the most volatile month of the year and China's commodity crunch

 

 

IN CASE YOU MISSED IT

 
 

 

Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel
Digital Products Feedback Privacy Policy  
© 2021 CNBC LLC. All rights reserved. A property of NBCUniversal.
900 Sylvan Avenue, Englewood Cliffs, NJ 07632
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis.
Data also provided by THOMSON REUTERS

Related Posts


EmoticonEmoticon

:)
:(
=(
^_^
:D
=D
=)D
|o|
@@,
;)
:-bd
:-d
:p
:ng
:lv